RECURRENT ADENOID CYSTIC CARCINOMA
Clinical trials for RECURRENT ADENOID CYSTIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ADENOID CYSTIC CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT ADENOID CYSTIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail targets genetic weakness in rare cancer
Disease control Recruiting nowThis study tests two different oral drug combinations in people with a rare type of salivary gland cancer called adenoid cystic carcinoma (ACC) that has a specific genetic change (NOTCH mutation). The goal is to see if combining a NOTCH-blocking drug (CB-103) with either abemacic…
Matched conditions: RECURRENT ADENOID CYSTIC CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Glenn J. Hanna • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug targets rare Cancer's genetic weakness
Disease control Recruiting nowThis study tests a new drug called REM-422 in people with advanced adenoid cystic carcinoma (ACC), a rare cancer of the glands. The drug works by breaking down a specific genetic message (MYB mRNA) that helps the cancer grow. The trial will enroll 125 participants to see if the d…
Matched conditions: RECURRENT ADENOID CYSTIC CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Remix Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC